TELLZY H 40 TAB 10 S

About

TELLZY H 40 combines Telmisartan, an angiotensin II receptor blocker (ARB), with Hydrochlorothiazide (HCTZ), a thiazide diuretic. Telmisartan works by blocking the action of angiotensin II, leading to relaxation of blood vessels and a decrease in blood pressure. HCTZ enhances the excretion of sodium and water by the kidneys, which further reduces blood volume and blood pressure. This combination is particularly effective for patients whose blood pressure is not adequately controlled by monotherapy with either agent. The synergistic action of these two drugs provides a more potent antihypertensive effect, helping to achieve target blood pressure levels and reduce the risk of cardiovascular events in patients with essential hypertension.

Uses

• Treatment of essential hypertension.
• Management of fluid retention (edema).
• Reduction of cardiovascular risk in high-risk patients.
• When monotherapy is insufficient for blood pressure control.

Directions For Use

Take this medication orally, usually once daily, with or without food, as directed by your physician.

Benefits

• Effective blood pressure reduction.
• Provides sustained blood pressure control.
• Reduces risk of heart attack and stroke.
• Offers dual mechanism of action for comprehensive management.
• Helps manage fluid retention.
• Improved patient compliance with combination therapy.

Side Effects

• Dizziness or lightheadedness
• Fatigue or weakness
• Headache
• Nausea
• Diarrhea
• Hypotension (low blood pressure)
• Electrolyte imbalances (e.g., hypokalemia, hyponatremia)
• Increased uric acid levels (hyperuricemia)
• Muscle cramps or weakness
• Dry mouth
• Elevated blood glucose levels
• Cough

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it can further lower blood pressure and increase the risk of dizziness or lightheadedness when taken with this medication.
• Pregnancy - This medication is contraindicated during pregnancy, especially in the second and third trimesters, due to the risk of fetal harm and death associated with Telmisartan.
• Breastfeeding - Consult your doctor. Both Telmisartan and Hydrochlorothiazide may pass into breast milk. The potential risks to the infant should be weighed against the benefits to the mother.
• Liver - Use with caution in patients with liver impairment. Dose adjustments may be necessary, and close monitoring of liver function is recommended, especially with the diuretic component.
• Kidney - Use with caution in patients with kidney impairment. Regular monitoring of kidney function and electrolytes is essential, and dose adjustments may be required due to both components.
• Lung - Generally safe for lung conditions, but caution is advised in patients with a history of allergic reactions to sulfonamide-derived drugs (like HCTZ).

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.